Canopy Growth Corporation (TSX:WEED)
Canada · Delayed Price · Currency is CAD | Market Cap | 549.95M -6.7% |
| Revenue (ttm) | 293.63M +6.8% |
| Net Income | -232.63M |
| EPS | -0.65 |
| Shares Out | 423.04M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 508,650 |
| Open | 1.290 |
| Previous Close | 1.310 |
| Day's Range | 1.290 - 1.320 |
| 52-Week Range | 1.180 - 3.280 |
| Beta | 2.42 |
| Analysts | Hold |
| Price Target | 2.02 (+55.39%) |
| Earnings Date | Nov 6, 2026 |
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-... [Read more]
Full Company ProfileFinancial Performance
In fiscal year 2026, Canopy Growth's revenue was 284.60 million, an increase of 5.80% compared to the previous year's 269.00 million. Losses were -262.91 million, -48.34% less than in 2025.
Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for WEED stock is "Hold." The 12-month stock price target is $2.02, which is an increase of 55.39% from the latest price.
News
Here is What to Know Beyond Why Canopy Growth Corporation (CGC) is a Trending Stock
Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Canopy Growth Proxy statement: Proxy filing
Canopy Growth filed a proxy statement on September 15, 2026, providing details for shareholder voting and corporate governance matters.
Canopy Growth Corporation (CGC) Advances While Market Declines: Some Information for Investors
Canopy Growth Corporation (CGC) reached $0.94 at the closing of the latest trading day, reflecting a +1.15% change compared to its last close.
Canopy Growth's Business Is Improving. So Why Isn't the Stock Performing Better?
Two long-standing issues continue to weigh on this cannabis stock.
Canopy Growth reminds shareholders vote ‘FOR’ items 1 through 6
Canopy Growth (CGC) Corporation reminds shareholders to vote ahead of its Annual General and Special Meeting of shareholders. “The board of directors of the Company recommends shareholders vote FOR It...
Canopy Growth Reminds Shareholders to Vote Ahead of September 23 Deadline
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives throu...
Canopy Growth broadens medical cannabis portfolio in Australia
Canopy Growth (CGC) announced a broadening of its medical cannabis portfolio in Australia across its Spectrum Therapeutics, Spectrum Therapeutics Reserve, 7ACRES, Tweed and Twd. brands. The expansion ...
Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats and Formulations
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives throu...
Canopy Growth's Revenue Grew 13% Last Quarter. Investors Barely Reacted.
Canopy Growth's revenue increased 13% year over year in its most recent fiscal quarter. Adjusted gross margin improved, while EBITDA losses narrowed sharply.
Should You Buy Canopy Growth Stock on the Rebound?
Canopy Growth is a large Canadian marijuana company. Over the past year, it has strengthened its financial position and made an acquisition.
Better Cannabis Stock to Buy Right Now: Canopy Growth or Tilray Brands?
The Canadian cannabis companies are both seeing strong growth, but one is a better buy right now.
3 Top Marijuana Stocks to Watch in September 2026
The cannabis industry is entering September, and investors are once again searching for opportunities across the sector. After years of volatility, several marijuana companies are showing signs of str...
Top Canadian Cannabis Stocks to Watch in August 2026
Canadian cannabis stocks are once again gaining attention as investors search for opportunities within the global marijuana industry. The sector has experienced significant changes since Canada legali...
Canopy Growth Proxy statement: Proxy filing
Canopy Growth filed a proxy statement on August 17, 2026, providing details for shareholder voting and corporate governance matters.
Canopy Growth announces mailing of proxy materials for special meeting
Canopy Growth (CGC) announced the Company has mailed its proxy statement and fiscal 2026 annual report to shareholders for its Annual General and Special Meeting of shareholders scheduled to take…
Canopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special Meeting – Urges Shareholders to Vote Now
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives throu...
Canopy Growth secures renewed EU GMP certification at Kincardine
Canopy Growth (CGC) Corporation announced that its Kincardine, Ontario cultivation facility has received renewed European Union Good Manufacturing Practice, EU GMP, certification from the Regierungspr...
Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target?
Curaleaf's bid signals cannabis consolidation is accelerating. Canopy Growth could emerge as another takeover candidate.
Marijuana reform is emerging as a midterm elections issue on both sides of the aisle
With November's pivotal midterm elections fast approaching, cannabis reform is emerging as an issue. Two states, Massachusetts and Idaho, will vote on ballot initiatives regarding legalization, and in...
Canopy Growth (CGC) Q1 2027 Earnings Call Transcript
Revenue grew 13% as MTL integration and Polish market strength drove results.
Canopy Growth Proxy statement: Proxy filing
Canopy Growth filed a proxy statement on August 14, 2026, providing details for shareholder voting and corporate governance matters.
Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives throu...
Will Canopy Growth Get Acquired?
Curaleaf recently announced plans for a takeover of Aurora Cannabis, a rival of Canopy Growth. Canopy Growth is an iconic cannabis company in Canada with a strong position in the market.
Canopy Growth Targets European Cannabis Expansion After MTL Deal and Cost Cuts
Canopy Growth NASDAQ: CGC is positioning itself for further expansion in medical cannabis, European markets and Canadian recreational cannabis after restructuring operations, reducing costs and acquir...
Canopy Growth Transcript: Canaccord Genuity's 46th Annual Growth Conference
Leadership has transformed the company into a focused consumer goods player, cutting costs and acquiring cultivation expertise. Strong positions in Canadian and European markets are supported by robust supply chains and premium brands, with a clear strategy to expand in Europe and improve margins.